建議您使用以下瀏覽器觀看合一網站，
以獲得最佳瀏覽效果。
如何使用IE找到Microsoft Edge?
-
開啟新分頁(紅色框)
-
於搜尋框中打入Edge(紅色框)，並按搜尋(藍色框)
-
點擊【立即啟動】(藍框處)打開 Microsoft Edge
Title
Oneness announces information about the first investor conference in 2025.
The medical device registration application of Bonvadis for all indications of wounds has been accepted by Australia TGA
Oneness has submitted 510(k) application of Bonvadis for full thickness wound indications to the U.S. FDA
Announcement for the Board of Directors' resolution to dispose of (sublease) part of a right-of-use assets to a related party.
Announcement for the Board of Directors' resolution to acquire part of a right-of-use assets to a related party.
The medical device registration application of Bonvadis for all indications of wounds has been accepted by Brazil ANVISA.
Oneness Biotech Co., Ltd., has been granted the Brazil Good Manufacturing Practice (B-GMP) certification for Bonvadis from Brazil ANVISA.
The medical device registration application of Bonvadis for all indications in wounds has been accepted by UAE MOHAP
Oneness Board of Directors resolved to convene the Annual Shareholders' Meeting of 2025.
The Board of Directors resolved not to distribute dividends.
The Company's 2024 consolidated financial statements have been approved by the Board of Directors
Oneness announces on behalf of major subsidiary Cotton Field Organic Farm Inc. about its Board of Directors resolve not to distribute dividends
Oneness announces on behalf of major subsidiary Cotton Field Organic Farm Inc. about its BOD resolution to convene the 2025 Annual Shareholders’meeting
Announcement of the date of the Company's board of directors meeting for the year ended December 31, 2024 Parent Company Only and Consolidated Financial Reports
Oneness Biotech to Present at Healthcare Conference Taipei 2025
建議您使用以下瀏覽器觀看合一網站，
以獲得最佳瀏覽效果。
如何使用IE找到Microsoft Edge?